Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter study

Journal of Clinical Virology

Volumn 79, Issue , 2016, Pages 68-73

  Loubet, Paul ^a,b,c   Samih Lenzi, Nezha ^a   Galtier, Florence ^d   Vanhems, Philippe ^e,f   Loulergue, Pierre ^a,c   Duval, Xavier ^g,h   Jouneau, Stéphane ^i,r   Postil, Déborah ^j   Rogez, Sylvie ^j   Valette, Martine ^k   Merle, Corinne ^d   Régis, Corinne ^l   Costa, Yolande ^g   Lesieur, Zineb ^a,o   Tattevin, Pierre ^i,r   Lina, Bruno ^k   Carrat, Fabrice ^m,n,s   Launay, Odile ^a,b,c,q   Seddik, K ^o   Lenzi, N ^o   Bonmarin, I ^p   Louler gue, P ^q   Bodilis, H ^q   Servera Miyalou, M ^q   Sadler, I ^q   Momcilovic, S ^q   R Kanaan, ^q   Coolent, N ^q   Boun, K Tan ^q   Blanche, P ^q   Charpentier, J ^q   Davi aud, F ^q   Mongardon, N ^q   Bretagnol, A ^q   Claessens, Y E ^q   Rozenberg, F ^q   Krivine, A ^q   Yazdanpanah, Y ^g   Burdet, C ^g   Harent, S ^g   Lachatre, M ^g   Rioux, C ^g   Bleibtreu, A ^g   Casalino, E ^g   Choquet, C ^g   Leleu, A ^g   Belghalem, K ^g   Colosi, L ^g   Ranaivoson, M ^g   Verry, V ^g   Pereira, L ^g   Dupeyrat, E ^g   Bernard, J ^g   Emeyrat, N ^g   Chavance, P ^g   Debit, A ^g   Aubier, M ^g   Pradere, P ^g   Justet, A ^g   Mal, H ^g   Brugiere, O ^g   Papo, T ^g   Goulenok, T ^g   Boisseau, M ^g   Jouenne, R ^g   Alexandra, J F ^g   Raynaud Simon, A ^g   Lilamand, M ^g   Cloppet Fontaine, A ^g   Becheur, K ^g   Pelletier, A L ^g   Fidouh, N ^g   Ralaimazava, P ^g   Beaumale, F ^g   Munier, E ^e   Betend, F ^e   Amour, S ^e   Loef fert, S ^e   Francourt, K ^e   Letois, F ^d   Foulongne, V ^d   Geraud P ^d   Driss, V ^d   Noslier, S ^d   Ray, M ^d   Sebbane, M ^d   Konate A ^d   Bourdin, A ^d   Klouche, K ^d   Leglise M S ^d   Couve Deacon, E ^j   Fruit, D ^j   Fenerol, C ^j   Vallejo, C ^j   Alain, S ^j   Laine F ^r   Thebault E ^r   Lagathu, G ^r   Fillatre, P ^r   Le Pape, C ^r   Beuzit, L ^r   Chau, F ^s   Goderel, I ^s   more..

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔTEL DIEU   (France)

^d HÔPITAL SAINT ELOI   (France)

^e EDOUARD HERRIOT HOSPITAL   (France)

^f CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^g BICHAT HOSPITAL   (France)

^h UNIVERSITÉ PARIS DIDEROT   (France)

ⁱ RENNES UNIVERSITY HOSPITAL   (France)

^j DUPUYTREN UNIVERSITY HOSPITAL   (France)

^k UNIVERSITÉ DE LYON   (France)

^l UNIVERSITÉ LYON 1   (France)

^m SORBONNE UNIVERSITÉ   (France)

ⁿ HÔPITAL SAINT ANTOINE   (France)

^o Innovative clinical research network in vaccinology   (France)

^p InVS   (France)

^q université Paris Cité   (France)

^r PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^s INSTITUT PIERRE LOUIS D EPIDÉMIOLOGIE ET DE SANTÉ PUBLIQUE   (France)

more..

Author keywords

Adults; Antiviral; Hospitalisation; Influenza; Severe; Vaccination

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR;

ACUTE HEART FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANTIVIRAL THERAPY; ARTICLE; DEMOGRAPHY; DYSPNEA; FEMALE; FRANCE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA A VIRUS; INFLUENZA B VIRUS; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY FAILURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEASONAL INFLUENZA; ADOLESCENT; AGE; CLINICAL TRIAL; COMORBIDITY; EPIDEMIOLOGY; INFLUENZA, HUMAN; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; EPIDEMIOLOGIC STUDIES; FEMALE; FRANCE; HOSPITALIZATION; HUMANS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84963740608     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2016.04.005     Document Type: Article

References (38)

1. WHO Influenza (Seasonal) [Internet]. WHO [cité 2015 aoÛt 5]; Available from:. http://www.who.int.gate2.%20inist.fr/mediacentre/factsheets/fs211/en/.
2. Thompson W.W., Shay D.K., Weintraub E., et al. Influenza-associated hospitalizations in the United States. JAMA 2004, 292:1333-1340.
3. Zhou H., Thompson W.W., Viboud C.G., Ringholz C.M., Cheng P.-Y., Steiner C., et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin. Infect. Dis. 2012, 54:1427-1436.
4. Hak E., Wei F., Nordin J., Mullooly J., Poblete S., Nichol K.L. Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-Dwelling elderly persons. J. Infect. Dis. 2004, 189:450-458.
5. Harper S.A., Bradley J.S., Englund J.A., File T.M., Gravenstein S., Hayden F.G., et al. Seasonal influenza in adults and Children-Diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the infectious diseases society of america. Clin. Infect. Dis. 2009, 48:1003-1032.
6. Reed C., Chaves S.S., Daily Kirley P., Emerson R., Aragon D., Hancock E.B., et al. Estimating influenza disease burden from population-Based surveillance data in the United States. PLoS One 2015, 10:e0118369.
7. Call S.A., Vollenweider M.A., Hornung C.A., Simel D.L., McKinney W. Does this patient have influenza. JAMA 2005, 293:987-997.
8. Falsey A.R., Murata Y., Walsh E.E. Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch. Intern. Med. 2007, 167:354-360.
9. Babcock H.M., Merz L.R., Dubberke E.R., Fraser V.J. Case-control study of clinical features of influenza in hospitalized patients. Infect. Control Hosp. Epidemiol. 2008, 29:921-926.
10. Walsh E.E., Cox C., Falsey A.R. Clinical features of influenza A virus infection in older hospitalized persons. J. Am. Geriatr. Soc. 2002, 50:1498-1503.
11. Lee N., Ison M.G. Diagnosis, management and outcomes of adults hospitalized with influenza. Antivir. Ther. 2012, 17:143-157.
12. Osterholm M.T., Kelley N.S., Sommer A., Belongia E.A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect. Dis. 2012, 12:36-44.
13. Grijalva C.G., Zhu Y., Williams D.J., et al. ASsociation between hospitalization with community-acquired laboratory-confirmed influenza pneumonia and prior receipt of influenza vaccination. JAMA 2015, 148:8-9. (7).
14. Talbot H.K., Zhu Y., Chen Q., Williams J.V., Thompson M.G., Griffin M.R. Effectiveness of influenza vaccine for preventing laboratory-Confirmed influenza hospitalizations in adults, 2011-2012 influenza season. Clin. Infect. Dis. 2013, 56:1774-1777.
15. Bonmarin I., Belchior E., Lévy-Bruhl D. Impact of influenza vaccination on mortality in the French elderly population during the 2000-2009 period. Vaccine 2015, 33:1099-1101.
16. Estimated Influenza Illnesses and Hospitalizations Averted by Influenza Vaccination - United States, 2012-13 Influenza Season [Internet]. [cité 2015 aoÛt 4]; Available from:. http://www.cdc.gov.gate2.inist.fr/mmwr/preview/mmwrhtml/mm6249a2.%20htm.
17. Louie J.K., Yang S., Acosta M., Yen C., Samuel M.C., Schechter R., et al. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2012, 55:1198-1204.
18. Lee N., Cockram C.S., Chan P.K.S., Hui D.S.C., Choi K.W., Sung J.J.Y. Antiviral treatment for patients hospitalized with severe influenza infection may affect clinical outcomes. Clin. Infect. Dis. 2008, 46:1323-1324.
19. McGeer A., Green K.A., Plevneshi A., Shigayeva A., Siddiqi N., Raboud J., et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin. Infect. Dis. 2007, 45:1568-1575.
20. Rondy M., Puig-Barbera J., Launay O., Duval X., Castilla J., Guevara M., et al. 2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a european network of hospitals. a pilot study. PLoS One 2013, 8:e59681.
21. Influenza case definitions [Internet]. [cité 2015 juin 17];Available from:. http://ecdc.europa.eu/en/activities/surveillance/eisn/surveillance/pages/influenza_case_definitions.aspx.
22. Castilla J., Godoy P., Domínguez Á., Martínez-Baz I., Astray J., Martín V., et al. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-Confirmed influenza. Clin. Infect. Dis. 2013, 57:167-175.
23. Monmany J., Rabella N., Margall N., Domingo P., Gich I., Vázquez G. Unmasking influenza virus infection in patients attended to in the emergency department. Infection 2004, 32:89-97.
24. Babcock H.M., Merz L.R., Fraser V.J. Is influenza an influenza-like illness: clinical presentation of influenza in hospitalized patients. Infect. Control Hosp. Epidemiol. 2006, 27:266-270.
25. Arriola C.S., Anderson E.J., Baumbach J., Bennett N., Bohm S., Hill M., et al. Does influenza vaccination modify influenza disease severity? Data on older adults hospitalized with influenza during the 2012-13 season in the United States. J. Infect. Dis. 2015.
26. Puig-Barberà J., Martinez C., Cano L., Diez J., López-Labrador F.X. Influenza H3N2 antigenic drift in hospital admissions with influenza during the 2014-2015 season in the Valencia Hospital Network for the study of influenza and respiratory viruses disease, Valencia (Spain). J. Clin. Virol. 2015, 70:S63.
27. Jefferson T., Di Pietrantonj C., Rivetti A., Bawazeer G.A., Al-Ansary L.A., Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst. Rev. 2010, CD001269.
28. Simonsen L., Taylor R.J., Viboud C., Miller M.A., Jackson L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect. Dis. 2007, 7:658-666.
29. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., Levandowski R.A. The efficacy of influenza vaccine in elderly Persons A meta-analysis and review of the literature. Ann. Intern. Med. 1995, 123:518-527.
30. Baxter R., Ray G.T., Fireman B.H. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine 2010, 28:7267-7272.
31. McLean H.Q., Meece J.K., Belongia E.A. Influenza vaccination and risk of hospitalization among adults with laboratory confirmed influenza illness. Vaccine 2014, 32:453-457.
32. Fireman B., Lee J., Lewis N., Bembom O., van der Laan M., Baxter R. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am. J. Epidemiol. 2009, 170:650-656.
33. Darvishian M., Gefenaite G., Turner R.M., Pechlivanoglou P., Van der Hoek W., Van den Heuvel E.R., et al. After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly. J. Clin. Epidemiol. 2014, 67:734-744.
34. Darvishian M., Bijlsma M.J., Hak E., van den Heuvel E.R. Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies. Lancet Infect. Dis. 2014, 14:1228-1239.
35. Lee N., Choi K.W., Chan P.K.S., Hui D.S.C., Lui G.C.Y., Wong B.C.K., et al. Outcomes of adults hospitalised with severe influenza. Thorax 2010, 65:510-515.
36. Moscona A. Neuraminidase inhibitors for influenza. N. Engl. J. Med. 2005, 353:1363-1373.
37. Kaiser L., Wat C., Mills T., Mahoney P., Ward P., Hayden F. IMpact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch. Intern. Med. 2003, 163:1667-1672.
38. Hiba V., Chowers M., Levi-Vinograd I., Rubinovitch B., Leibovici L., Paul M. Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study. J. Antimicrob. Chemother. 2011, 66:1150-1155.